Company profile
Tectonic Therapeutic, Inc.
NASDAQ:TECXBiotechnology: Biological Products (No Diagnostic Substances)
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06616974 | phase2 | active_not_recruiting | 2024-09-04 | 2026-11-24 | Tectonic Therapeutic | A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) |
FDA applications (0)
No records yet.